Pro Data Export
SciClone Pharmaceuticals Key Statistics
Current Valuation
Dividends and Shares
| Shares Outstanding | 54.01M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin Quarterly | 83.93% |
| Profit Margin Quarterly | 5.70% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 4.457 |
| Debt to Equity Ratio | 0.0101 |
| Free Cash Flow | 2.477M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 8.95% |
| Year to Date Stock Returns | 13.00% |
| 1 Year Stock Returns | -16.03% |
| 3 Year Stock Returns | 37.96% |
| 52 Week High | 7.58 |
| 52 Week Low | 3.68 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | -24.70M |
| Cash from Investing TTM | -1.203M |
| Cash from Operations TTM | 43.52M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 84.23M |
| Long Term Debt | 1.445M |
| Total Assets | 174.07M |
| Liabilities | 31.05M |
| Shareholders Equity | 143.02M |
| Book Value | 143.02M |
| Book Value Per Share | 2.648 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
SCLN News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SCLN | 4.87 | +0.02 | +0.41% | 263.02M |
New watchlist
